Author

SN Sanyal

Professor at Panjab University, Chandigarh, INDIA - Cited by 3,299 - Cancer cell and molecular biology

Biography

Dr. Sanyal SN is currently working in the Department of Biophysics, Panjab University, Chandigarh, India. Her international experience includes various programs, contributions, and participation in different countries for diverse fields of study.
Title
Cited by
Year
Chemoprevention of DMH-induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin
MK Saini, K Vaiphei, SN SanyalMolecular and cellular biochemistry 361, 217-228, 2012201
80
2012
Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer
C Rana, H Piplani, V Vaish, B Nehru, SN SanyalMolecular and cellular biochemistry 402, 225-241, 2015201
77
2015
Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer
S Setia, B Nehru, SN SanyalBiomedicine & Pharmacotherapy 68 (8), 1023-1029, 2014201
69
2014
55
2012
Role of GSK-3β in regulation of canonical Wnt/β-catenin signaling and PI3-K/Akt oncogenic pathway in colon cancer
S Jain, P Ghanghas, C Rana, SN SanyalCancer investigation 35 (7), 473-483, 2017201
44
2017
Activation of NF-κB: Bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis
S Setia, B Nehru, SN SanyalBiomedicine & Pharmacotherapy 68 (1), 119-128, 2014201
43
2014
Anti-proliferative action of silibinin on human colon adenomatous cancer HT-29 cells
R Akhtar, M Ali, S Mahmood, SN SanyalNutricion hospitalaria 29 (2), 388-392, 2014201
40
2014
Role of cytokines and Jak3/Stat3 signaling in the 1, 2-Dimethylhydrazine Dihydrochloride-induced rat model of colon carcinogenesis
MK Saini, V Vaish, SN SanyalEuropean Journal of Cancer Prevention 22 (3), 215-228, 2013201
40
2013
Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer
P Ghanghas, S Jain, C Rana, SN SanyalBiomedicine & Pharmacotherapy 78, 239-247, 2016201
38
2016
The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor
S Setia, B Nehru, SN SanyalBiomedicine & Pharmacotherapy 68 (6), 721-727, 2014201
35
2014